Abstract Archives of the RSNA, 2014
CAE165
The Transition to Quantitative Cardiac Imaging: Navigating Quantitative Maps— Where Do We Stand and Where Do We Go from Here?
Education Exhibits
Presented in 2014
Jad Marwan Bou Ayache MD, Presenter: Nothing to Disclose
Marcos Paulo Ferreira Botelho MD, Abstract Co-Author: Nothing to Disclose
James Christopher Carr MD, Abstract Co-Author: Research Grant, Astellas Group
Research support, Siemens AG
Speaker, Siemens AG
Advisory Board, Guerbet SA
Benjamin Freed, Abstract Co-Author: Nothing to Disclose
Oisin Jude Flanagan MBBCh, MRCPI, Abstract Co-Author: Nothing to Disclose
Daniel Lee, Abstract Co-Author: Research funded, CardiacAssist, Inc
Spouse, Employee, Takeda Pharmaceutical Company Limited
Jeremy Douglas Collins MD, Abstract Co-Author: Consultant, B. Braun Melsungen AG
1. Review the techniques for in vivo myocardial T1 and T2 quantitative imaging.
2. Summarize literature supporting the clinical utility of quantitative myocardial T1 and T2 imaging.
3. Review of clinical cases illustrating the clinical benefit of integrating quantitative T1 and T2 imaging into cardiac MRI protocols.
1. The need for quantitative imaging to supplement qualitative MRI examination.
2. T1 parametric mapping
a) History and Background, highlighting the pitfalls of quantitative approaches on conventional delayed enhancement imaging sequences.
b) Physical principles
c) Review different pulse sequences for quantitative T1 imaging.
d) Summarize the literature supporting the clinical utility of quantitative T1 imaging at cardiac MRI.
3. T2 parametric mapping
a) History and Background, highlighting the pitfalls of qualitative interpretation of T2 weighted dark blood imaging.
b) Physical principles
c) Review different approache for quantitative T2 imaging.
d) Summarize the literature supporting the clinical utility of quantitative T2 imaging at cardiac MRI.
4. Case examples
a) T2 quantitative imaging: myocarditis, vasculitis, infarction, takotsubo cardiomyopathy, and heart transplant rejection.
b) T1 quantitative imaging : amyloidosis, scleroderma, endomyocardial fibroelastosis, thrombus, and HCM.
http://abstract.rsna.org/uploads/2014/14012461/14012461_tgm5.pdf
Bou Ayache, J,
Botelho, M,
Carr, J,
Freed, B,
Flanagan, O,
Lee, D,
Collins, J,
The Transition to Quantitative Cardiac Imaging: Navigating Quantitative Maps— Where Do We Stand and Where Do We Go from Here?. Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL.
http://archive.rsna.org/2014/14012461.html